Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

China flag China · Delayed Price · Currency is CNY
26.52
-0.27 (-1.01%)
Mar 11, 2026, 11:29 AM CST
-1.08%
Market Cap 3.63B
Revenue (ttm) 1.31B
Net Income (ttm) 147.59M
Shares Out 135.44M
EPS (ttm) 1.09
PE Ratio 24.58
Forward PE n/a
Dividend 0.40 (1.53%)
Ex-Dividend Date Jun 13, 2025
Volume 242,420
Average Volume 767,671
Open 26.79
Previous Close 26.79
Day's Range 26.51 - 26.96
52-Week Range 19.97 - 33.34
Beta 0.15
RSI 47.52
Earnings Date Apr 28, 2026

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material techno... [Read more]

Sector Healthcare
Founded 2000
Employees 711
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603351
Full Company Profile

Financial Performance

In 2024, SHA:603351's revenue was 1.30 billion, an increase of 12.19% compared to the previous year's 1.16 billion. Earnings were 146.42 million, an increase of 30.50%.

Financial Statements

News

There is no news available yet.